Drug Shortage Report for INTRON A

Last updated on 2021-03-13 History
Report ID 131940
Drug Identification Number 02223406
Brand name INTRON A
Common or Proper name interferon alfa-2b lyophilized powder
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) INTERFERON ALFA-2B WATER
Strength(s) 10000000UNIT 1ML
Dosage form(s) LIQUID POWDER FOR SOLUTION
Route of administration INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size vial
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-02-19
Actual start date 2021-02-19
Estimated end date 2021-03-19
Actual end date 2021-03-12
Shortage status Resolved
Updated date 2021-03-13
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-03-13 English Compare
v11 2021-03-12 French Compare
v10 2021-03-12 English Compare
v9 2021-03-11 English Compare
v8 2021-02-20 English Compare
v7 2021-02-19 English Compare
v6 2021-02-19 French Compare
v5 2021-02-19 English Compare
v4 2021-02-16 English Compare
v3 2021-02-15 English Compare
v2 2021-01-19 French Compare
v1 2021-01-19 English Compare